Syndax Pharmaceuticals
SNDX
SNDX
218 hedge funds and large institutions have $1.26B invested in Syndax Pharmaceuticals in 2025 Q1 according to their latest regulatory filings, with 33 funds opening new positions, 88 increasing their positions, 61 reducing their positions, and 26 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
218
Holders Change
+3
Holders Change %
+1.4%
% of All Funds
2.96%
Holding in Top 10
10
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+25%
% of All Funds
0.14%
New
33
Increased
88
Reduced
61
Closed
26
Calls
$18.1M
Puts
$7.88M
Net Calls
+$10.2M
Net Calls Change
-$2.9M
Top Buyers
| 1 |
EP
Eversept Partners
New York
|
+$47.5M |
| 2 |
Bank of America
Charlotte,
North Carolina
|
+$32.3M |
| 3 |
Point72 Asset Management
Stamford,
Connecticut
|
+$25.7M |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$22.4M |
| 5 |
Balyasny Asset Management
Chicago,
Illinois
|
+$21.5M |
Top Sellers
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
-$51.6M |
| 2 |
Morgan Stanley
New York
|
-$37.2M |
| 3 |
ACA
Avoro Capital Advisors
New York
|
-$30.1M |
| 4 |
Goldman Sachs
New York
|
-$24.9M |
| 5 |
SCM
Soleus Capital Management
Greenwich,
Connecticut
|
-$20.6M |
